Coronavirus: Be prepared for the next outbreak

Coronaviruses are able to cause massive disease outbreaks. These infectious viruses can trigger severe respiratory diseases which sometimes even lead to death. A new real-time RT-PCR test helps to [...]

Mosquito-borne diseases: Here’s how to detect zika, malaria & co.

What would you say is the world’s most dangerous animal? A wolf? A shark? Wrong – it’s the mosquito. Mosquitoes transmit diseases causing over a million deaths every year. For World Mosquito Day, [...]

Illness due to parasites: What you need to know about zoonoses

Zoonoses are infectious diseases which can be transmitted from animals to humans. More than 200 of these diseases are known. On World Zoonoses Day on July 6 we are presenting the most common [...]

Adalimumab monitoring improves therapy success

The drug adalimumab is used very successfully in the treatment of various inflammatory diseases. Yet in some patients, the efficacy of this drug decreases over time. We explain why this is so and how [...]

World IBD Day: Five myths about inflammatory bowel diseases

May is completely characterized by intestinal health: first Digestive Disease Week, now World IBD Day. The aim of the IBD action day is to raise awareness about inflammatory bowel diseases (IBDs). [...]

Therapeutic drug monitoring: Greater efficiency through quick tests

Therapeutic drug monitoring (TDM) is used to measure the concentration of an active ingredient in the patient’s blood. Using this information, physicians can adjust the dose individually to the [...]

Malaria: Rapid diagnostic testing is crucial

April 25 is World Malaria Day: A good opportunity to take a look at the current prophylaxis, diagnosis, and treatment of this dangerous tropical disease that claims around 400,000 lives each year.

Colon cancer awareness month: Early detection can save lives

As every year, March is officially “Colon Cancer Awareness Month”. A great opportunity to highlight the importance of screening. Nowadays, modern tests have made the early detection of colon [...]

Better therapy, lower costs: Optimizing the treatment of IBD

So-called TNFα blockers are commonly used in the treatment of inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. Therapeutic drug monitoring improves the effect of the [...]

Helicobacter pylori & its resistance against clarithromycin – detect it simultaneously!

RIDA®GENE Helicobacter pylori is a sensitive and specific real-time PCR assay. It simultaneously detects and differentiates Helicobacter pylori and its resistance to clarithromycin in human tissue [...]

RIDA®GENE MRSA: Excellent quality assessment result

Excellent results of the RIDA®GENE MRSA real-time PCR assay in the external quality assessment program of Instand e.V. Repeatedly, the R-Biopharm AG participated successfully in the INSTAND external [...]

Safe into the upcoming influenza season with RIDA®GENE real-time PCR assays

The RIDA®GENE real-time PCR assays  (RIDA®GENE Flu, RIDA®GENE Flu LC2.0, RIDA®GENE Flu & RSV)  successfully detected the suggested vaccination strains for influenca of the 2015/2016 season.

Differentiation of IBD and IBS with Calprotectin in Stool

It is often difficult to differentiate patients with inflammatory bowel disease (IBD) those who suffer from irritable bowel syndrome due to similar symptoms of patients. Both groups show similar [...]

TNFalpha Blocker and Drug Monitoring

TNFalpha blocker are biologic agents, which are used for the treatment of inflammatory diseases such as Ulcerative Colitis, Crohns disease and Rheumatoid Arthritis. Infliximab (Remicade®, RemsimaTM, [...]

Calprotectin predicts relaps after stopping TNFα treatment

Molander et al. investigated if concentrations of fecal calprotectin can be used for predicting relaps after stopping TNFα blocking therapy in patients with Ulcerative Colitis and Morbus Crohn.

Drug Monitoring reduces Infliximab treatment costs

Study about first randomized, controlled testing shows that clinical treatment decisions based on therapeutic drug monitoring (TDM) is superior to dose-intensification strategy. One common way of [...]

Influenza season 2015 dominated by new influenza A variant (H3N2)

The RIDA®GENE real-time PCR assays for the detection of Influenza (RIDA®GENE Flu, RIDA®GENE Flu LC2.0, RIDA®GENE Flu & RSV) detect the currently circulating drift variant of influenza A (H3N2).

Drug Monitoring of Infliximab Biosimilars RemsimaTM and Inflectra®

Ann Gils and her colleagues from KU Leuven evaluated if the biosimilars RemsimaTM and Inflectra® were equally well quantified as Remicade® (Infliximab, IFX) in their clinically validated infliximab assay.

Legionella and mycoplasma pneumoniae: New RIDA®GENE products for detection of atypical CAP bacteria

Community-acquired pneumonia (CAP) is the most common fatal infectious disease in western countries. Bacteria are the most common pathogens causing CAP, where one differentiates between typical and [...]

Therapeutic Drug Monitoring of Infliximab (Remicade®)

RIDASCREEN® IFX Monitoring is an enzyme linked immunoassay intended for the quantitative determination of infliximab (IFX, Remicade®, anti-TNFα) in human serum and plasma.  It is the commercialized [...]

3rd time in a row: Deloitte Sustained Excellence Award

Sustainable excellence in longterm and profitable growth awarded   After awards in 2010 and 2013, R-Biopharm AG has won the Deloitte Sustained Excellence Award for the third time in a row this [...]

RIDA®GENE Enterovirus: New real-time RT-PCR assay

RIDA®GENE Enterovirus PCR test – New real-time RT-PCR Assay for the detection of the major human enteroviruses   Human enteroviruses comprise a variety of different pathogens: poliovirus, [...]

RIDA qLine® Allergy: The next generation of allergy in-vitro diagnostics

The Next Generation of Allergy In-Vitro-Diagnostics R-Biopharm AG has faced the challenge to develop a sophisticated allergy in vitro test system that combines both a quantitative determination and a [...]

RIDA®QUICK Clostridium difficile GDH

With its latest rapid test, R-Biopharm is now able to offer a complete solution for the immunological diagnosis of Clostridium difficile in compliance with the new international guidelines of various [...]

New rapid test format of RIDA®QUICK Norovirus available

Progress in reliability at simplified work flow The RIDA®QUICK Norovirus Test is a qualitative immunochromatographic lateral flow rapid test for determining Genogroup 1 (GG I) and Genogroup 2 (GG II) [...]

Pancreatic Elastase ELISA now available

From now on R-Biopharm expands its portfolio in the Gastroenterology product group The Pancreatic Elastase ELISA (G09038) for the quantitative determination of pancreatic elastase in feces enables to [...]

N2403 RIDA®QUICK Campylobacter

RIDA®QUICK Campylobacter is an new immunochromatographic rapid test for qualitative detection of Campylobacter jejuni and Campylobacter coli antigens in stool samples and cultures. It is quite [...]

C0701 RIDASCREEN® Clostridium difficile GDH

Der RIDASCREEN® Clostridium difficile GDH is an Enzymimmunoassay for qualitative detection of Clostridium difficile specific Glutamatdehydrogenase in stool samples and cultures. It is intended as [...]

C2401 RIDASCREEN® Campylobacter

The RIDASCREEN®Campylobacter is an improving new Elisa testformat for qualitative detection of Campylobacter jejuni and Campylobacter coli antigens in stool samples and cultures. It substitutes the [...]

New: RIDA®GENE MRSA multiplex real-time PCR

Reliable MRSA Screening for Hospitals and Laboratories in less than 2 hours. Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most dreaded causes of nosocomial infections in hospitals [...]

RIDASCREEN® Stuhlröhrchen

R-Biopharm AG is pleased to inform you about a new design of an accessory for our parameters for the gastroenterology ELISAs RIDASCREEN® Stuhlröhrchen – stool collection tubes for easy, rapid [...]

RIDA®LINE Helicobacter IgG & IgA

New line blot immunoassays – Reliable differentiation between human IgG and IgA antibodies against Helicobacter pylori type I and II strains. More than half of the world population is infected with [...]

RIDA®GENE ETEC/EIEC multiplex real-time PCR completes the RIDA®GENE product portfolio for the detection of pathogenic E. coli

RIDA®GENE ETEC/EIEC enables a specific and direct detection of the major pathogens of traveller’s diarrhea: ETEC/EIEC and Shigella spp. in less than 2 hours. Enterotoxigenic E.coli (ETEC) are the [...]

RIDA®QUICK C.difficile Toxin A/B — Reliable Toxin Detection in a Rapid Test

R-Biopharm AG has developed a one-step rapid test based on lateral flow technology. This simple test enables direct detection of C. difficile toxins A and B in well homogenized stool samples in only [...]

Fastest of its kind: New molecular biological test for the specific detection of EHEC bacteria

R-Biopharm (Darmstadt) has brought to the market the fastest assay currently available for the specific detection of enterohemorrhagic Escherichia coli (EHEC). With the new RIDA®GENE EHEC/EPEC rapid [...]

RIDA®GENE EHEC/EPEC multiplex real-time PCR: Specific and direct detection of the lethal EHEC bacteria in less than 2 hours

Currently an increased number of diseases and suspected cases are linked to the intestinal pathogen EHEC (enterohämorrhagic E. coli). Noticeable are the numbers of severe diseases with complications [...]

Histamin release assays for cellular allergy diagnostics and autoreactive urticaria

The Danish company REFLAB became a member of the R-Biopharm group on January 1, 2010. As a supplier of test kits for the detection of autoreactive urticaria and histamine release tests for the [...]

RIDASCREEN® Norovirus 3rd Generation antigen EIA

Your first step in the diagnosis of noroviral gastroenteritis outbreaks, powered by R-Biopharm Noroviruses, the most common cause of acute gastroenteritis are estimated to cause 21 million people [...]

RIDA®GENE Norovirus

For the MEDICA 2009 the real-time RT-PCR for the qualitative detection of noroviruses of the genogroups I and II in human stool samples will be available. The highly sensitive and specific real-time [...]

Rida News III/2000

Fusarium toxin levels found to be too high in infant food Control values für DON and Zearalenon in feed AOAC approval for the RIDASCREEN® FAST DON test RIDASCREEN® FAST folic acid RIDASCREEN® [...]

Start typing and press Enter to search